Filter
340
Text search:
formulations
Featured
Recommendations
51
New Publications
84
Language
Document type
No document type
174
Guidelines
83
Studies & Reports
48
Manuals
15
Strategic & Response Plan
7
Infographics
4
Fact sheets
4
Training Material
3
App
1
Resource Platforms
1
Countries / Regions
India
16
Kenya
15
Global
11
Western and Central Europe
8
Ghana
7
Malawi
7
South Africa
6
Tanzania
5
Rwanda
5
Bangladesh
5
Sierra Leone
4
Nigeria
4
Senegal
4
Ethiopia
4
Syria
4
Africa
4
Burkina Faso
3
Nepal
3
Zambia
3
Botswana
3
South–East Asia Region
3
Latin America and the Carribbean
3
Eastern Europe
3
Congo, Democratic Republic of
2
Mali
2
Côte d’Ivoire / Ivory Coast
2
Cameroon
2
Uganda
2
Zimbabwe
2
Haiti
2
Benin
2
Middle East and North Africa
2
Russia
2
France
2
Guinea
1
Liberia
1
Niger
1
Philippines
1
Pakistan
1
South Sudan
1
Afghanistan
1
Cambodia
1
Eswatini/ Swaziland
1
Colombia
1
Madagascar
1
Myanmar / Burma
1
Sri Lanka
1
Yemen
1
East and Southern Africa
1
Bhutan
1
Venezuela
1
Congo-Brazzaville
1
Tajikistan
1
Authors & Publishers
Publication Years
Category
Countries
91
Clinical Guidelines
75
Public Health
21
Women & Child Health
21
Key Resources
13
Pharmacy & Technologies
6
Capacity Building
3
Toolboxes
HIV
50
TB
34
Pharmacy
23
COVID-19
22
Mental Health
17
AMR
17
NTDs
15
NCDs
10
Caregiver
9
Rapid Response
8
Polio
6
Disability
5
Conflict
5
Ebola & Marburg
4
Planetary Health
4
2.0 Rapid Response
4
Refugee
3
Malaria
3
Natural Hazards
2
Specific Hazards
2
Cholera
1
Zika
1
Global Health Education
1
10–21 March 2014
This document is the national level companion to a broader document on health care facility level developed by the WHO Health Emergencies Programme for national level stakeholders
Schistosomiasis is a public health problem in tropical and subtropical regions of Africa, Asia, the Caribbean and South America. It is one of the neglected tropical diseases (NTDs) - a group of diseases and conditions that affect particularly low-income populations, worldwide.
Last year, WHO laun
...
La schistosomiase humaine est une maladie parasitaire chronique et aigüe causée par une infection par des douves du sang (vers trématodes) du genre Schistosoma. Cette maladie est un problème de santé publique dans les zones tropicales et
subtropicales d’Afrique, d’Asie, des Caraïbes et d
...
Externalizing disorders
Chapter D.1
Attention deficit hyperactivity disorder
This paper has been commissioned by RedR to identify gaps in skills, technology, and knowledge in urban humanitarian response in order to inform RedR’s project Ready to Respond which is looking to address these gaps in two specific areas:
Water supply, sanitation, and hygiene; Shelter res
...
Environmental Health in Emergencies and Disasters
Chapter 10
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial agents in development worldwide. It evaluates to what extent
...
Although Shiga toxin-producing Escherichia coli (STEC) have been isolated from a variety of food production animals, they are most commonly associated with ruminants from which we derive meat and milk. Because of the widespread and diverse nature of ruminant-derived food production, coupled with the
...
This report is one of the first major products of the newly established Precision Public Health Metrics unit of the UCN cluster of the WHO Regional Office for Africa. The report presents national trends in communicable and non-communicable disease burden and control in the WHO African region. It tra
...
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
Polio vaccines: WHO position paper – June 2022
recommended
This position paper on polio vaccines replaces the 2016 WHO position paper, and summarizes recent developments in the field.
This document provides up-to-date guidance on laboratory studies as well as smallscale (semi-field) and large-scale field trials to assess the efficacy and determine field application rates of new molluscicide products for control of schistosomiasis.
